(Q51497020)

5 April 2018

title

The physiology of amylin and insulin: maintaining the balance between glucose secretion and glucose uptake. (English)

1 reference

5 April 2018

0 references

Catherine Martin

1

1 reference

5 April 2018

publication date

1 May 2006

1 reference

5 April 2018

The Science of Diabetes Self-Management and Care

published in

1 reference

5 April 2018

volume

32 Suppl 3

1 reference

5 April 2018

page(s)

101S-104S

1 reference

5 April 2018

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Clinical implications of amylin and amylin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Glucagon physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Relationships of upper gastrointestinal motor and sensory function with glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706288S237

10.1177/0145721706288S237

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018